利用超极化碳-13磁共振成像评估多部位高级别浆液性卵巢癌新辅助化疗的早期反应
这项前瞻性研究纳入8例高级别浆液性卵巢癌患者,在首周期新辅助化疗前后行超极化[1-13C]丙酮酸磁共振成像与[18F]-FDG PET/CT检查。研究发现肿瘤乳酸标记速率在不同解剖部位间相似且与肿瘤体积无关,kPL与卵巢/盆腔转移灶的PET SUVmax正相关(R=0.471,P=0.02),首周期化疗后乳酸标记下降与病理反应相关。
要点
- 超极化13C MRI可快速标记多部位腹部转移灶的内源性肿瘤乳酸池。
- kPL与卵巢/盆腔转移灶[18F]-FDG PET的SUVmax正相关(R=0.471,P=0.02)。
- 首周期新辅助化疗后乳酸标记下降与病理反应相关。
核心结论
- 这项探索性研究显示13C MRI测量具有评估高级别浆液性卵巢癌患者新辅助化疗早期反应的潜力。
研究设计与样本
- 前瞻性研究纳入8例高级别浆液性卵巢癌患者,在首周期新辅助化疗前后行13C MRI与[18F]-FDG PET/CT检查,并将影像参数与临床及组织病理学参数比较。
主要发现
- 超极化[1-13C]丙酮酸13C MRI在多处腹部转移灶中快速标记内源性肿瘤乳酸池,标记速率在不同解剖病变部位间相似且与肿瘤体积无关。
- 描述丙酮酸与乳酸间13C标记交换的表观速率常数kPL与卵巢/盆腔转移性肿瘤沉积的[18F]-FDG PET标准摄取值SUVmax正相关(R=0.471,P=0.02)。
- 首周期新辅助化疗后可检测到乳酸标记下降,且与病理反应相关。
- 在一例缺乏完全组织病理学反应的患者中,乳酸标记未见整体下降。
- kPL与癌组织LDHA浓度相关(rho=0.641;P=0.02)。
局限性
- 原文将本研究定性为探索性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate the capability of hyperpolarized [1-13C] pyruvate MRI to predict pathologic response to neoadjuvant treatment in multi-site abdominopelvic disease of high-grade serous ovarian cancer (HGSOC) patients and to compare 13C MRI and [18F]-FDG PET/CT measurements for detecting early treatment response. We recruited eight patients with HGSOC in this prospective study who underwent 13C MRI and [18F]-FDG PET/CT before and after the first cycle of neoadjuvant chemotherapy treatment (NACT). Imaging parameters were compared with clinical and histophatologic parameters. RESULTS: We demonstrate here that 13C MRI of hyperpolarized [1-13C]pyruvate metabolism in multiple abdominal metastases resulted in rapid labeling of the endogenous tumor lactate pool. The rate of labeling was similar between the different anatomical disease sites and independent of tumor volume. The apparent rate constant describing exchange of 13C label between pyruvate and lactate (kPL) was positively correlated with PET standard uptake values (SUVmax) for [18F]-FDG in metastatic tumor deposits in the ovary/pelvis (R = 0.471, P = 0.02). Decreased lactate labeling could be detected after the first cycle of neoadjuvant chemotherapy and was associated with pathological response. There was no overall decrease in lactate labeling in a single patient who lacked a complete histopathologic response. kPL was associated with cancer tissue LDHA concentration (rho = 0.641; P = 0.02). CONCLUSION: This exploratory study demonstrates the potential of 13C MRI measurements for assessing early response to neoadjuvant chemotherapy in patients with HGSOC.
引用
- Beer L, Bura V, Ursprung S, et al. Assessment of early response to neoadjuvant chemotherapy in multi-site high-grade serous ovarian cancer using hyperpolarized-13C MRI. EJNMMI Res. 2025. PMID: 40246745. doi:10.1186/s13550-025-01219-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。